nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—CYP3A4—bone cancer	0.789	1	CbGaD
Flurazepam—SLC22A2—Cisplatin—bone cancer	0.0303	0.58	CbGbCtD
Flurazepam—Apprehension—Cisplatin—bone cancer	0.00912	0.106	CcSEcCtD
Flurazepam—ABCB1—Cisplatin—bone cancer	0.00808	0.154	CbGbCtD
Flurazepam—ABCB1—Doxorubicin—bone cancer	0.00541	0.103	CbGbCtD
Flurazepam—ABCB1—Methotrexate—bone cancer	0.00524	0.1	CbGbCtD
Flurazepam—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00417	0.0674	CbGpPWpGaD
Flurazepam—Slurred speech—Cisplatin—bone cancer	0.00391	0.0454	CcSEcCtD
Flurazepam—CYP3A4—Doxorubicin—bone cancer	0.00324	0.062	CbGbCtD
Flurazepam—Dysarthria—Cisplatin—bone cancer	0.00185	0.0214	CcSEcCtD
Flurazepam—CYP2A6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00173	0.028	CbGpPWpGaD
Flurazepam—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00137	0.0221	CbGpPWpGaD
Flurazepam—Clomipramine—GSTP1—bone cancer	0.00136	0.127	CrCbGaD
Flurazepam—Anaphylactoid reaction—Cisplatin—bone cancer	0.00131	0.0152	CcSEcCtD
Flurazepam—Quinacrine—CYP3A4—bone cancer	0.00124	0.116	CrCbGaD
Flurazepam—Irritability—Cisplatin—bone cancer	0.00121	0.0141	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.00114	0.0133	CcSEcCtD
Flurazepam—Chloroquine—CYP3A4—bone cancer	0.0011	0.103	CrCbGaD
Flurazepam—Abdominal discomfort—Cisplatin—bone cancer	0.00105	0.0122	CcSEcCtD
Flurazepam—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00103	0.0168	CbGpPWpGaD
Flurazepam—Dysarthria—Methotrexate—bone cancer	0.00101	0.0118	CcSEcCtD
Flurazepam—GABRQ—Orphan transporters—TUBB4B—bone cancer	0.001	0.0163	CbGpPWpGaD
Flurazepam—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000999	0.0162	CbGpPWpGaD
Flurazepam—Thinking abnormal—Epirubicin—bone cancer	0.00098	0.0114	CcSEcCtD
Flurazepam—GABRR2—Mecp2 and Associated Rett Syndrome—EZH2—bone cancer	0.000975	0.0158	CbGpPWpGaD
Flurazepam—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000969	0.0157	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.000969	0.0157	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000967	0.0157	CbGpPWpGaD
Flurazepam—Dysarthria—Epirubicin—bone cancer	0.000949	0.011	CcSEcCtD
Flurazepam—Gait disturbance—Epirubicin—bone cancer	0.00092	0.0107	CcSEcCtD
Flurazepam—Thinking abnormal—Doxorubicin—bone cancer	0.000907	0.0105	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Epirubicin—bone cancer	0.000898	0.0104	CcSEcCtD
Flurazepam—Dysarthria—Doxorubicin—bone cancer	0.000878	0.0102	CcSEcCtD
Flurazepam—Coma—Methotrexate—bone cancer	0.000876	0.0102	CcSEcCtD
Flurazepam—Salivary hypersecretion—Epirubicin—bone cancer	0.000872	0.0101	CcSEcCtD
Flurazepam—GABRQ—Orphan transporters—TUBB2A—bone cancer	0.000867	0.014	CbGpPWpGaD
Flurazepam—Gait disturbance—Doxorubicin—bone cancer	0.000851	0.00988	CcSEcCtD
Flurazepam—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.000836	0.0135	CbGpPWpGaD
Flurazepam—Phosphatase alkaline increased—Doxorubicin—bone cancer	0.00083	0.00964	CcSEcCtD
Flurazepam—GABRG3—Orphan transporters—TUBB4B—bone cancer	0.000827	0.0134	CbGpPWpGaD
Flurazepam—Coma—Epirubicin—bone cancer	0.00082	0.00952	CcSEcCtD
Flurazepam—GABRB1—Orphan transporters—TUBB4B—bone cancer	0.000815	0.0132	CbGpPWpGaD
Flurazepam—Flushing—Cisplatin—bone cancer	0.000814	0.00945	CcSEcCtD
Flurazepam—Salivary hypersecretion—Doxorubicin—bone cancer	0.000806	0.00936	CcSEcCtD
Flurazepam—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000804	0.013	CbGpPWpGaD
Flurazepam—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000789	0.0128	CbGpPWpGaD
Flurazepam—Mental disability—Epirubicin—bone cancer	0.000779	0.00904	CcSEcCtD
Flurazepam—GABRA6—Orphan transporters—TUBB4B—bone cancer	0.000771	0.0125	CbGpPWpGaD
Flurazepam—GABRA4—Orphan transporters—TUBB4B—bone cancer	0.000761	0.0123	CbGpPWpGaD
Flurazepam—Coma—Doxorubicin—bone cancer	0.000759	0.00881	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.000749	0.00869	CcSEcCtD
Flurazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000739	0.012	CbGpPWpGaD
Flurazepam—Mental disability—Doxorubicin—bone cancer	0.000721	0.00836	CcSEcCtD
Flurazepam—Vision blurred—Cisplatin—bone cancer	0.00072	0.00836	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Methotrexate—bone cancer	0.000719	0.00835	CcSEcCtD
Flurazepam—GABRG3—Orphan transporters—TUBB2A—bone cancer	0.000714	0.0116	CbGpPWpGaD
Flurazepam—Lethargy—Methotrexate—bone cancer	0.00071	0.00825	CcSEcCtD
Flurazepam—GABRB1—Orphan transporters—TUBB2A—bone cancer	0.000703	0.0114	CbGpPWpGaD
Flurazepam—GABRB2—Orphan transporters—TUBB4B—bone cancer	0.000696	0.0113	CbGpPWpGaD
Flurazepam—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000693	0.00804	CcSEcCtD
Flurazepam—Leukopenia—Cisplatin—bone cancer	0.000684	0.00794	CcSEcCtD
Flurazepam—GABRA5—Orphan transporters—TUBB4B—bone cancer	0.000676	0.0109	CbGpPWpGaD
Flurazepam—Anaphylactoid reaction—Epirubicin—bone cancer	0.000673	0.00781	CcSEcCtD
Flurazepam—GABRA6—Orphan transporters—TUBB2A—bone cancer	0.000666	0.0108	CbGpPWpGaD
Flurazepam—Lethargy—Epirubicin—bone cancer	0.000665	0.00772	CcSEcCtD
Flurazepam—Irritability—Methotrexate—bone cancer	0.000664	0.00771	CcSEcCtD
Flurazepam—GABRA3—Orphan transporters—TUBB4B—bone cancer	0.000664	0.0108	CbGpPWpGaD
Flurazepam—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.000661	0.0107	CbGpPWpGaD
Flurazepam—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.00066	0.0107	CbGpPWpGaD
Flurazepam—GABRA4—Orphan transporters—TUBB2A—bone cancer	0.000657	0.0106	CbGpPWpGaD
Flurazepam—Ataxia—Methotrexate—bone cancer	0.000655	0.0076	CcSEcCtD
Flurazepam—GABRA2—Orphan transporters—TUBB4B—bone cancer	0.000653	0.0106	CbGpPWpGaD
Flurazepam—GABRB3—Orphan transporters—TUBB4B—bone cancer	0.000649	0.0105	CbGpPWpGaD
Flurazepam—Anxiety—Cisplatin—bone cancer	0.000648	0.00752	CcSEcCtD
Flurazepam—GABRG2—Orphan transporters—TUBB4B—bone cancer	0.000637	0.0103	CbGpPWpGaD
Flurazepam—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000635	0.0103	CbGpPWpGaD
Flurazepam—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000635	0.0103	CbGpPWpGaD
Flurazepam—Clonazepam—CYP3A4—bone cancer	0.000633	0.0592	CrCbGaD
Flurazepam—Anaphylactic shock—Cisplatin—bone cancer	0.000624	0.00724	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000623	0.00723	CcSEcCtD
Flurazepam—Lethargy—Doxorubicin—bone cancer	0.000615	0.00714	CcSEcCtD
Flurazepam—Ataxia—Epirubicin—bone cancer	0.000613	0.00711	CcSEcCtD
Flurazepam—Hyperhidrosis—Cisplatin—bone cancer	0.000603	0.007	CcSEcCtD
Flurazepam—GABRB2—Orphan transporters—TUBB2A—bone cancer	0.000601	0.00973	CbGpPWpGaD
Flurazepam—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000597	0.00967	CbGpPWpGaD
Flurazepam—Anorexia—Cisplatin—bone cancer	0.000594	0.0069	CcSEcCtD
Flurazepam—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000589	0.00953	CbGpPWpGaD
Flurazepam—Clotiazepam—CYP3A4—bone cancer	0.000587	0.055	CrCbGaD
Flurazepam—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000587	0.00681	CcSEcCtD
Flurazepam—GABRA5—Orphan transporters—TUBB2A—bone cancer	0.000584	0.00945	CbGpPWpGaD
Flurazepam—Hypotension—Cisplatin—bone cancer	0.000583	0.00676	CcSEcCtD
Flurazepam—Abdominal discomfort—Methotrexate—bone cancer	0.000577	0.0067	CcSEcCtD
Flurazepam—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000574	0.00929	CbGpPWpGaD
Flurazepam—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.000573	0.00928	CbGpPWpGaD
Flurazepam—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000568	0.00659	CcSEcCtD
Flurazepam—Ataxia—Doxorubicin—bone cancer	0.000567	0.00658	CcSEcCtD
Flurazepam—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000566	0.00917	CbGpPWpGaD
Flurazepam—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.000564	0.00912	CbGpPWpGaD
Flurazepam—GABRB3—Orphan transporters—TUBB2A—bone cancer	0.00056	0.00906	CbGpPWpGaD
Flurazepam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000557	0.00901	CbGpPWpGaD
Flurazepam—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000557	0.00901	CbGpPWpGaD
Flurazepam—Dyspnoea—Cisplatin—bone cancer	0.000556	0.00645	CcSEcCtD
Flurazepam—Alprazolam—CYP3A4—bone cancer	0.000555	0.0519	CrCbGaD
Flurazepam—Clobazam—CYP3A4—bone cancer	0.000555	0.0519	CrCbGaD
Flurazepam—GABRG2—Orphan transporters—TUBB2A—bone cancer	0.00055	0.0089	CbGpPWpGaD
Flurazepam—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000543	0.0063	CcSEcCtD
Flurazepam—Decreased appetite—Cisplatin—bone cancer	0.000542	0.00629	CcSEcCtD
Flurazepam—Quazepam—CYP3A4—bone cancer	0.000538	0.0504	CrCbGaD
Flurazepam—Drowsiness—Methotrexate—bone cancer	0.000536	0.00623	CcSEcCtD
Flurazepam—Sweating—Methotrexate—bone cancer	0.000514	0.00597	CcSEcCtD
Flurazepam—Feeling abnormal—Cisplatin—bone cancer	0.000514	0.00596	CcSEcCtD
Flurazepam—Flunitrazepam—CYP3A4—bone cancer	0.000508	0.0476	CrCbGaD
Flurazepam—Drowsiness—Epirubicin—bone cancer	0.000502	0.00583	CcSEcCtD
Flurazepam—Agranulocytosis—Methotrexate—bone cancer	0.000501	0.00581	CcSEcCtD
Flurazepam—Sweating—Epirubicin—bone cancer	0.000481	0.00559	CcSEcCtD
Flurazepam—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000481	0.00778	CbGpPWpGaD
Flurazepam—Estazolam—CYP3A4—bone cancer	0.000475	0.0445	CrCbGaD
Flurazepam—Agranulocytosis—Epirubicin—bone cancer	0.000469	0.00544	CcSEcCtD
Flurazepam—Drowsiness—Doxorubicin—bone cancer	0.000465	0.00539	CcSEcCtD
Flurazepam—Adinazolam—CYP3A4—bone cancer	0.000452	0.0423	CrCbGaD
Flurazepam—Asthenia—Cisplatin—bone cancer	0.000447	0.00519	CcSEcCtD
Flurazepam—Sweating—Doxorubicin—bone cancer	0.000445	0.00517	CcSEcCtD
Flurazepam—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000443	0.00716	CbGpPWpGaD
Flurazepam—Clomipramine—CYP3A4—bone cancer	0.000438	0.0411	CrCbGaD
Flurazepam—Prazepam—CYP3A4—bone cancer	0.000437	0.0409	CrCbGaD
Flurazepam—Agranulocytosis—Doxorubicin—bone cancer	0.000434	0.00503	CcSEcCtD
Flurazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000432	0.00699	CbGpPWpGaD
Flurazepam—Diarrhoea—Cisplatin—bone cancer	0.000427	0.00495	CcSEcCtD
Flurazepam—Flushing—Epirubicin—bone cancer	0.000418	0.00486	CcSEcCtD
Flurazepam—Dysgeusia—Methotrexate—bone cancer	0.000411	0.00477	CcSEcCtD
Flurazepam—Triazolam—CYP3A4—bone cancer	0.000407	0.0381	CrCbGaD
Flurazepam—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000399	0.00646	CbGpPWpGaD
Flurazepam—Vomiting—Cisplatin—bone cancer	0.000396	0.0046	CcSEcCtD
Flurazepam—Vision blurred—Methotrexate—bone cancer	0.000395	0.00459	CcSEcCtD
Flurazepam—Rash—Cisplatin—bone cancer	0.000393	0.00456	CcSEcCtD
Flurazepam—Dermatitis—Cisplatin—bone cancer	0.000393	0.00456	CcSEcCtD
Flurazepam—Temazepam—CYP3A4—bone cancer	0.00039	0.0365	CrCbGaD
Flurazepam—Flushing—Doxorubicin—bone cancer	0.000387	0.00449	CcSEcCtD
Flurazepam—Tension—Epirubicin—bone cancer	0.000385	0.00447	CcSEcCtD
Flurazepam—Dysgeusia—Epirubicin—bone cancer	0.000384	0.00446	CcSEcCtD
Flurazepam—Nervousness—Epirubicin—bone cancer	0.000381	0.00442	CcSEcCtD
Flurazepam—Midazolam—CYP3A4—bone cancer	0.000378	0.0354	CrCbGaD
Flurazepam—Leukopenia—Methotrexate—bone cancer	0.000375	0.00436	CcSEcCtD
Flurazepam—Nausea—Cisplatin—bone cancer	0.00037	0.0043	CcSEcCtD
Flurazepam—Vision blurred—Epirubicin—bone cancer	0.00037	0.00429	CcSEcCtD
Flurazepam—Agitation—Epirubicin—bone cancer	0.000361	0.00419	CcSEcCtD
Flurazepam—Chest pain—Methotrexate—bone cancer	0.000357	0.00414	CcSEcCtD
Flurazepam—Arthralgia—Methotrexate—bone cancer	0.000357	0.00414	CcSEcCtD
Flurazepam—Tension—Doxorubicin—bone cancer	0.000356	0.00414	CcSEcCtD
Flurazepam—Dysgeusia—Doxorubicin—bone cancer	0.000355	0.00413	CcSEcCtD
Flurazepam—Nervousness—Doxorubicin—bone cancer	0.000353	0.00409	CcSEcCtD
Flurazepam—Syncope—Epirubicin—bone cancer	0.000352	0.00408	CcSEcCtD
Flurazepam—Leukopenia—Epirubicin—bone cancer	0.000351	0.00408	CcSEcCtD
Flurazepam—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000347	0.00562	CbGpPWpGaD
Flurazepam—Palpitations—Epirubicin—bone cancer	0.000347	0.00402	CcSEcCtD
Flurazepam—Confusional state—Methotrexate—bone cancer	0.000345	0.004	CcSEcCtD
Flurazepam—Loss of consciousness—Epirubicin—bone cancer	0.000345	0.004	CcSEcCtD
Flurazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000343	0.00555	CbGpPWpGaD
Flurazepam—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000342	0.00554	CbGpPWpGaD
Flurazepam—Anaphylactic shock—Methotrexate—bone cancer	0.000342	0.00397	CcSEcCtD
Flurazepam—Vision blurred—Doxorubicin—bone cancer	0.000342	0.00397	CcSEcCtD
Flurazepam—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000341	0.00553	CbGpPWpGaD
Flurazepam—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000339	0.00549	CbGpPWpGaD
Flurazepam—Chest pain—Epirubicin—bone cancer	0.000334	0.00388	CcSEcCtD
Flurazepam—Arthralgia—Epirubicin—bone cancer	0.000334	0.00388	CcSEcCtD
Flurazepam—Agitation—Doxorubicin—bone cancer	0.000334	0.00387	CcSEcCtD
Flurazepam—Anxiety—Epirubicin—bone cancer	0.000333	0.00386	CcSEcCtD
Flurazepam—Hyperhidrosis—Methotrexate—bone cancer	0.000331	0.00384	CcSEcCtD
Flurazepam—Dry mouth—Epirubicin—bone cancer	0.000327	0.00379	CcSEcCtD
Flurazepam—Anorexia—Methotrexate—bone cancer	0.000326	0.00379	CcSEcCtD
Flurazepam—Syncope—Doxorubicin—bone cancer	0.000326	0.00378	CcSEcCtD
Flurazepam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000325	0.00526	CbGpPWpGaD
Flurazepam—Leukopenia—Doxorubicin—bone cancer	0.000325	0.00377	CcSEcCtD
Flurazepam—Diazepam—CYP3A4—bone cancer	0.000324	0.0303	CrCbGaD
Flurazepam—Confusional state—Epirubicin—bone cancer	0.000323	0.00375	CcSEcCtD
Flurazepam—Palpitations—Doxorubicin—bone cancer	0.000321	0.00372	CcSEcCtD
Flurazepam—Anaphylactic shock—Epirubicin—bone cancer	0.00032	0.00372	CcSEcCtD
Flurazepam—Hypotension—Methotrexate—bone cancer	0.00032	0.00371	CcSEcCtD
Flurazepam—Loss of consciousness—Doxorubicin—bone cancer	0.000319	0.0037	CcSEcCtD
Flurazepam—Shock—Epirubicin—bone cancer	0.000315	0.00366	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000312	0.00362	CcSEcCtD
Flurazepam—Hyperhidrosis—Epirubicin—bone cancer	0.00031	0.00359	CcSEcCtD
Flurazepam—Chest pain—Doxorubicin—bone cancer	0.000309	0.00359	CcSEcCtD
Flurazepam—Arthralgia—Doxorubicin—bone cancer	0.000309	0.00359	CcSEcCtD
Flurazepam—Anxiety—Doxorubicin—bone cancer	0.000308	0.00358	CcSEcCtD
Flurazepam—Anorexia—Epirubicin—bone cancer	0.000305	0.00354	CcSEcCtD
Flurazepam—Dyspnoea—Methotrexate—bone cancer	0.000305	0.00354	CcSEcCtD
Flurazepam—Somnolence—Methotrexate—bone cancer	0.000304	0.00353	CcSEcCtD
Flurazepam—Dry mouth—Doxorubicin—bone cancer	0.000302	0.00351	CcSEcCtD
Flurazepam—Dyspepsia—Methotrexate—bone cancer	0.000301	0.0035	CcSEcCtD
Flurazepam—GABRB3—BDNF signaling pathway—EIF2S1—bone cancer	0.000301	0.00487	CbGpPWpGaD
Flurazepam—Chlorpromazine—CYP3A4—bone cancer	0.000301	0.0282	CrCbGaD
Flurazepam—Hypotension—Epirubicin—bone cancer	0.000299	0.00347	CcSEcCtD
Flurazepam—Confusional state—Doxorubicin—bone cancer	0.000299	0.00347	CcSEcCtD
Flurazepam—Decreased appetite—Methotrexate—bone cancer	0.000297	0.00345	CcSEcCtD
Flurazepam—Anaphylactic shock—Doxorubicin—bone cancer	0.000296	0.00344	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000292	0.00339	CcSEcCtD
Flurazepam—Shock—Doxorubicin—bone cancer	0.000291	0.00338	CcSEcCtD
Flurazepam—Hyperhidrosis—Doxorubicin—bone cancer	0.000286	0.00332	CcSEcCtD
Flurazepam—Dyspnoea—Epirubicin—bone cancer	0.000285	0.00331	CcSEcCtD
Flurazepam—Somnolence—Epirubicin—bone cancer	0.000285	0.0033	CcSEcCtD
Flurazepam—Anorexia—Doxorubicin—bone cancer	0.000282	0.00328	CcSEcCtD
Flurazepam—Feeling abnormal—Methotrexate—bone cancer	0.000282	0.00327	CcSEcCtD
Flurazepam—Dyspepsia—Epirubicin—bone cancer	0.000282	0.00327	CcSEcCtD
Flurazepam—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000281	0.00455	CbGpPWpGaD
Flurazepam—Gastrointestinal pain—Methotrexate—bone cancer	0.00028	0.00325	CcSEcCtD
Flurazepam—Decreased appetite—Epirubicin—bone cancer	0.000278	0.00323	CcSEcCtD
Flurazepam—Hypotension—Doxorubicin—bone cancer	0.000277	0.00321	CcSEcCtD
Flurazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000274	0.00444	CbGpPWpGaD
Flurazepam—Constipation—Epirubicin—bone cancer	0.000274	0.00318	CcSEcCtD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000273	0.00442	CbGpPWpGaD
Flurazepam—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000271	0.00438	CbGpPWpGaD
Flurazepam—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00027	0.00313	CcSEcCtD
Flurazepam—Dyspnoea—Doxorubicin—bone cancer	0.000264	0.00307	CcSEcCtD
Flurazepam—Feeling abnormal—Epirubicin—bone cancer	0.000264	0.00306	CcSEcCtD
Flurazepam—Somnolence—Doxorubicin—bone cancer	0.000263	0.00306	CcSEcCtD
Flurazepam—Gastrointestinal pain—Epirubicin—bone cancer	0.000262	0.00304	CcSEcCtD
Flurazepam—Dyspepsia—Doxorubicin—bone cancer	0.000261	0.00303	CcSEcCtD
Flurazepam—Decreased appetite—Doxorubicin—bone cancer	0.000258	0.00299	CcSEcCtD
Flurazepam—GABRR1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000257	0.00416	CbGpPWpGaD
Flurazepam—Constipation—Doxorubicin—bone cancer	0.000253	0.00294	CcSEcCtD
Flurazepam—Asthenia—Methotrexate—bone cancer	0.000245	0.00285	CcSEcCtD
Flurazepam—GABRQ—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000245	0.00397	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000245	0.00397	CbGpPWpGaD
Flurazepam—Feeling abnormal—Doxorubicin—bone cancer	0.000244	0.00283	CcSEcCtD
Flurazepam—Gastrointestinal pain—Doxorubicin—bone cancer	0.000242	0.00281	CcSEcCtD
Flurazepam—Pruritus—Methotrexate—bone cancer	0.000242	0.00281	CcSEcCtD
Flurazepam—Diarrhoea—Methotrexate—bone cancer	0.000234	0.00272	CcSEcCtD
Flurazepam—Asthenia—Epirubicin—bone cancer	0.00023	0.00267	CcSEcCtD
Flurazepam—Pruritus—Epirubicin—bone cancer	0.000227	0.00263	CcSEcCtD
Flurazepam—Dizziness—Methotrexate—bone cancer	0.000226	0.00263	CcSEcCtD
Flurazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000222	0.0036	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000222	0.00359	CbGpPWpGaD
Flurazepam—Diarrhoea—Epirubicin—bone cancer	0.000219	0.00254	CcSEcCtD
Flurazepam—Vomiting—Methotrexate—bone cancer	0.000218	0.00253	CcSEcCtD
Flurazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000217	0.00351	CbGpPWpGaD
Flurazepam—Rash—Methotrexate—bone cancer	0.000216	0.0025	CcSEcCtD
Flurazepam—Dermatitis—Methotrexate—bone cancer	0.000216	0.0025	CcSEcCtD
Flurazepam—Headache—Methotrexate—bone cancer	0.000214	0.00249	CcSEcCtD
Flurazepam—Asthenia—Doxorubicin—bone cancer	0.000213	0.00247	CcSEcCtD
Flurazepam—Dizziness—Epirubicin—bone cancer	0.000212	0.00246	CcSEcCtD
Flurazepam—GABRR2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000212	0.00343	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000212	0.00343	CbGpPWpGaD
Flurazepam—Pruritus—Doxorubicin—bone cancer	0.00021	0.00243	CcSEcCtD
Flurazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000207	0.00335	CbGpPWpGaD
Flurazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000207	0.00335	CbGpPWpGaD
Flurazepam—Vomiting—Epirubicin—bone cancer	0.000204	0.00236	CcSEcCtD
Flurazepam—Nausea—Methotrexate—bone cancer	0.000203	0.00236	CcSEcCtD
Flurazepam—Diarrhoea—Doxorubicin—bone cancer	0.000203	0.00235	CcSEcCtD
Flurazepam—GABRG3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000202	0.00327	CbGpPWpGaD
Flurazepam—Rash—Epirubicin—bone cancer	0.000202	0.00234	CcSEcCtD
Flurazepam—Dermatitis—Epirubicin—bone cancer	0.000202	0.00234	CcSEcCtD
Flurazepam—Headache—Epirubicin—bone cancer	0.000201	0.00233	CcSEcCtD
Flurazepam—GABRB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000199	0.00322	CbGpPWpGaD
Flurazepam—Dizziness—Doxorubicin—bone cancer	0.000196	0.00227	CcSEcCtD
Flurazepam—Nausea—Epirubicin—bone cancer	0.00019	0.00221	CcSEcCtD
Flurazepam—Vomiting—Doxorubicin—bone cancer	0.000188	0.00219	CcSEcCtD
Flurazepam—GABRA6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000188	0.00305	CbGpPWpGaD
Flurazepam—Rash—Doxorubicin—bone cancer	0.000187	0.00217	CcSEcCtD
Flurazepam—Dermatitis—Doxorubicin—bone cancer	0.000187	0.00217	CcSEcCtD
Flurazepam—GABRA4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000186	0.00301	CbGpPWpGaD
Flurazepam—Headache—Doxorubicin—bone cancer	0.000186	0.00215	CcSEcCtD
Flurazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000182	0.00294	CbGpPWpGaD
Flurazepam—Nausea—Doxorubicin—bone cancer	0.000176	0.00204	CcSEcCtD
Flurazepam—GABRG3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000174	0.00282	CbGpPWpGaD
Flurazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000173	0.00281	CbGpPWpGaD
Flurazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000173	0.00281	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000172	0.00278	CbGpPWpGaD
Flurazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00017	0.00276	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00017	0.00275	CbGpPWpGaD
Flurazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000168	0.00272	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000165	0.00267	CbGpPWpGaD
Flurazepam—GABRR1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000163	0.00264	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000163	0.00263	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000162	0.00263	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00016	0.0026	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000159	0.00258	CbGpPWpGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000159	0.00257	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000158	0.00256	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000157	0.00254	CbGpPWpGaD
Flurazepam—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000156	0.00252	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000156	0.00252	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—BRAF—bone cancer	0.000156	0.00252	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000155	0.00252	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000149	0.00242	CbGpPWpGaD
Flurazepam—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000148	0.00239	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000147	0.00238	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000146	0.00236	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000146	0.00236	CbGpPWpGaD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000143	0.00232	CbGpPWpGaD
Flurazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000143	0.00231	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000143	0.00231	CbGpPWpGaD
Flurazepam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000142	0.00229	CbGpPWpGaD
Flurazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000141	0.00228	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00014	0.00227	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000139	0.00226	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000138	0.00223	CbGpPWpGaD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000137	0.00221	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000137	0.00221	CbGpPWpGaD
Flurazepam—GABRR1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000137	0.00221	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000136	0.0022	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000134	0.00218	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000134	0.00217	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000134	0.00216	CbGpPWpGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000133	0.00215	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000131	0.00213	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000131	0.00212	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—MDM2—bone cancer	0.00013	0.00211	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—MDM2—bone cancer	0.00013	0.00211	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000128	0.00207	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000128	0.00207	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000126	0.00204	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—BRAF—bone cancer	0.000125	0.00202	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000125	0.00202	CbGpPWpGaD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00012	0.00194	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—BRAF—bone cancer	0.000119	0.00193	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—BRAF—bone cancer	0.000119	0.00193	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—BRAF—bone cancer	0.000119	0.00193	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000118	0.00191	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—BRAF—bone cancer	0.000118	0.00191	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000117	0.0019	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000117	0.00189	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000116	0.00188	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000116	0.00188	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000115	0.00186	CbGpPWpGaD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000115	0.00186	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000113	0.00182	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000112	0.00181	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00011	0.00178	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000108	0.00175	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000108	0.00174	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000107	0.00174	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000106	0.00171	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—BRAF—bone cancer	0.000105	0.0017	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—MDM2—bone cancer	0.000105	0.00169	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000103	0.00166	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000101	0.00164	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000101	0.00163	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—BRAF—bone cancer	0.0001	0.00163	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—MDM2—bone cancer	0.0001	0.00162	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—MDM2—bone cancer	9.99e-05	0.00162	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—MDM2—bone cancer	9.99e-05	0.00162	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	9.96e-05	0.00161	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—MDM2—bone cancer	9.88e-05	0.0016	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	9.86e-05	0.0016	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	9.86e-05	0.0016	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—BRAF—bone cancer	9.81e-05	0.00159	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NDUFA12—bone cancer	9.76e-05	0.00158	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—BRAF—bone cancer	9.67e-05	0.00156	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	9.61e-05	0.00155	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—JUN—bone cancer	9.51e-05	0.00154	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—BRAF—bone cancer	9.15e-05	0.00148	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	9.03e-05	0.00146	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—BRAF—bone cancer	9.03e-05	0.00146	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	8.98e-05	0.00145	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NDUFA12—bone cancer	8.96e-05	0.00145	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—MDM2—bone cancer	8.78e-05	0.00142	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	8.62e-05	0.0014	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	8.62e-05	0.00139	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	8.47e-05	0.00137	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—MDM2—bone cancer	8.41e-05	0.00136	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	8.26e-05	0.00134	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—BRAF—bone cancer	8.26e-05	0.00134	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—MDM2—bone cancer	8.22e-05	0.00133	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	8.18e-05	0.00132	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—MDM2—bone cancer	8.1e-05	0.00131	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NT5C3A—bone cancer	8.08e-05	0.00131	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.07e-05	0.00131	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—BRAF—bone cancer	8.03e-05	0.0013	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	7.91e-05	0.00128	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—BRAF—bone cancer	7.88e-05	0.00128	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—BRAF—bone cancer	7.74e-05	0.00125	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—BRAF—bone cancer	7.69e-05	0.00125	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—MDM2—bone cancer	7.66e-05	0.00124	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	7.66e-05	0.00124	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	7.64e-05	0.00124	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—MDM2—bone cancer	7.57e-05	0.00122	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—BRAF—bone cancer	7.56e-05	0.00122	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NT5C3A—bone cancer	7.42e-05	0.0012	CbGpPWpGaD
Flurazepam—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.23e-05	0.00117	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	7.22e-05	0.00117	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NDUFA12—bone cancer	7.08e-05	0.00115	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—MDM2—bone cancer	6.92e-05	0.00112	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.84e-05	0.00111	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.82e-05	0.0011	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—MDM2—bone cancer	6.72e-05	0.00109	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	6.63e-05	0.00107	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—BRAF—bone cancer	6.6e-05	0.00107	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—MDM2—bone cancer	6.6e-05	0.00107	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—MDM2—bone cancer	6.49e-05	0.00105	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—MDM2—bone cancer	6.45e-05	0.00104	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—MDM2—bone cancer	6.33e-05	0.00102	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—BRAF—bone cancer	6.06e-05	0.000981	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.88e-05	0.000952	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NT5C3A—bone cancer	5.86e-05	0.000949	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—MDM2—bone cancer	5.53e-05	0.000896	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NDUFA12—bone cancer	5.33e-05	0.000863	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—MDM2—bone cancer	5.08e-05	0.000822	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.07e-05	0.00082	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.69e-05	0.000758	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.62e-05	0.000748	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NT5C3A—bone cancer	4.42e-05	0.000715	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.76e-05	0.000608	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.62e-05	0.000586	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ENO2—bone cancer	3.54e-05	0.000573	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—DHFR—bone cancer	3.28e-05	0.000532	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NDUFA12—bone cancer	3.28e-05	0.000531	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.27e-05	0.000529	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ENO2—bone cancer	3.25e-05	0.000526	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GNA11—bone cancer	3.07e-05	0.000497	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—DHFR—bone cancer	3.02e-05	0.000488	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GNA11—bone cancer	2.82e-05	0.000456	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP3A4—bone cancer	2.78e-05	0.000451	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NT5C3A—bone cancer	2.72e-05	0.00044	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ENO2—bone cancer	2.57e-05	0.000416	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.57e-05	0.000416	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP3A4—bone cancer	2.56e-05	0.000414	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—DHFR—bone cancer	2.38e-05	0.000386	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTP1—bone cancer	2.38e-05	0.000385	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GNA11—bone cancer	2.23e-05	0.000361	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTP1—bone cancer	2.19e-05	0.000354	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.16e-05	0.000349	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP3A4—bone cancer	2.02e-05	0.000327	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ENO2—bone cancer	1.93e-05	0.000313	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—DHFR—bone cancer	1.79e-05	0.00029	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTP1—bone cancer	1.73e-05	0.00028	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GNA11—bone cancer	1.68e-05	0.000271	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP3A4—bone cancer	1.52e-05	0.000246	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTP1—bone cancer	1.3e-05	0.00021	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTGS2—bone cancer	1.23e-05	0.0002	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ENO2—bone cancer	1.19e-05	0.000193	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTGS2—bone cancer	1.13e-05	0.000183	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—DHFR—bone cancer	1.11e-05	0.000179	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GNA11—bone cancer	1.03e-05	0.000167	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTGS2—bone cancer	8.95e-06	0.000145	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTP1—bone cancer	8.01e-06	0.00013	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTGS2—bone cancer	6.74e-06	0.000109	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTGS2—bone cancer	4.15e-06	6.72e-05	CbGpPWpGaD
